Enhanced expression of the protein kinase substrate annexin I in human hepatocellular carcinoma

Hepatology

Volumn 24, Issue 1, 1996, Pages 72-81

  Masaki, Tsutomu ^a,b   Tokuda, Masaaki ^a   Ohnishi, Makoto ^a   Watanabe, Seishiro ^a   Fujimura, Takashi ^a   Miyamoto, Kazuhiro ^a   Itano, Toshifumi ^a   Matsui, Hideki ^a   Arima, Keiji ^a   Shirai, Mutsunori ^a   Maeba, Takashi ^a   Sogawa, Kenichi ^a   Konishi, Ryoji ^a   Taniguchi, Kiyohide ^b   Hatanaka, Yoshio ^b   Hatase, Osamu ^a   Nishioka, Mikio ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b Takamatsu National Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOCORTIN 1; MESSENGER RNA; PROTEIN KINASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ENZYME SUBSTRATE; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; IN SITU HYBRIDIZATION; LIVER CELL CARCINOMA; MALIGNANT TRANSFORMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RNA ANALYSIS;

EID: 15844375461     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v24.pm0008707286     Document Type: Article

References (63)

1. Crumpton MJ, Dedman JR. Protein terminology tangle. Nature 1990;345: 12.
2. v-src and of the epidermal growth factor receptor/kinase. Cell 1986;46:191-199.
3. Schlaepfer DD, Haigler HT. Characterization of calcium-dependent phospholipid binding and phosphorylation of lipocortin I. J Biol Chem 1987; 262:6931-6938.
4. 2+-dependent manner. Proc Natl Acad Sci U S A 1996;83:4258-4262.
5. Saris CJM, Tack BF, Kristensen T, Glenney JR, Hunter T. The cDNA sequence for protein-tyrosine kinase substrate p36 (calpactin I heavy chain) reveals a multidomain protein with internal repeats. Cell 1986;46: 201-212.
6. 2+-dependent membrane-binding proteins. Nature 1986;320:636-638.
7. 2+ and phospholipids. Trends Biochem Sci 1986;11:420-423.
8. Sudhof TC, Slaughter CA, Leznicki I, Barjon P, Reynolds GA. Human 67-kDa calelectrin contains a duplication of four repeats found in 35-kDa lipocortins. Proc Natl Acad Sci U S A 1988;85:664-668.
9. Smith VI, Dedman JR. An immunological comparison of several novel calcium-binding proteins. J Biol Chem 1986;261:15815-15818.
10. Funakoshi T, Hendrickson LE, McMullen BA, Fujikawa K. Primary structure of human placental anticoagulant protein. Biochemistry 1987;26: 8087-8092.
11. 2+-modulated lipid binding proteins. EMBO J 1980;6:1599-1604.
12. Schlaepfer DD, Mehlman T, Burgess WH, Haigler HT. Structural and functional characterization of endonexin II, a calcium- and phospholipid-binding protein. Proc Natl Acad Sci U S A 1987;84:6078-6082.
13. Blackwell GJ, Carnuccio R, DiRosa M, Flower RJ, Parente L, Persico P. Macrocortin: a polypeptide causing the anti-phospholipase effects of glucocorticoid. Nature 1980;287:147-149.
14. Flower RJ, Wood JN, Parente L. Macrocortin and the mechanism of action of the glucocorticoids. Adv Inflammation Res 1984;7:61-70.
15. Creutz CE, Zakas WJ, Hamman HC, Crane S, Martin WH, Gould KL, Oddie KM, et al. Identification of chromaffin granule-binding proteins. J Biol Chem 1987;262:1860-1868.
16. Khanna NC, Tokuda M, Waisman DM. Purification of three forms of lipocortin from bovine lung. Cell Calcium 1987;8:217-228.
17. 2. Cell 1986;46:149-150.
18. Fava RA, Cohen S. Isolation of a calcium-dependent 35 kilodalton substrate for the epidermal growth factor receptor/kinase from A-431 cells. J Biol Chem 1984;259:2636-2645.
19. Sawyer ST, Cohen S. Epidermal growth factor stimulates the phosphorylation of the calcium-dependent 35,000 dalton substrate in intact A-431 cells. J Biol Chem 1985;260:8233-8236.
20. Guigni TD, James LC, Haigler HT. Epidermal growth factor stimulates tyrosine phosphorylation of specific proteins in permiabilized human fibroblast. J Biol Chem 1985;260:15081-15090.
21. Pepinsky RB, Sinclair LK. Epidermal growth factor-dependent phosphorylation of lipocortin. Nature 1986;321:81-84.
22. Kaetzel MA, Hazarika P, Dedman JR. Differential tissue expression of three 35-kDa annexin calcium-dependent phospholipid-binding proteins. J Biol Chem 1989;264:14463-14470.
23. De BK, Misono KS, Lukas TJ, Mroczkowski B, Cohen S. A calcium-dependent 35-kilodalton substrate for epidermal growth factor receptor/kinase isolated from normal tissue. J Biol Chem 1986;261:13784-13792.
24. Khanna NC, Tokuda M, Chony SM, Waisman DM. Phosphorylation of p36 in vitro by protein kinase C. Biochem Biophys Res Commun 1986;137: 397-403.
25. Flower RJ. Lipocortin and the mechanism of action of the glucocorticoids. Br J Pharmacol 1988;94:987-1001.
26. Drust D, Creutz C. Aggregation of the chromaffin granules by calpactin at micromolar levels of calcium. Nature 1988;331:88-91.
27. Burgone RD. Calpactin in exocytosis? Nature 1988;331:20.
28. Ohnishi M, Tokuda M, Masaki M, Fujimura T, Tai Y, Matsui H, Itano T, et al. Changes in annexin I and II levels during the postnatal development of rat pancreatic islets. J Cell Sci 1994;107:2117-2125.
29. Violette SM, King I, Browning JL, Pepinsky RB, Wallner BP, Sartorelli AC. Role of lipocortin I in the glucocorticoid induction of the terminal differentiation of a human squamous carcinoma. J Cell Physiol 1990;142: 70-77.
30. Horlick KR, Ganjianpour M, Frost SC, Nick HS. Annexin-I regulation in response to suckling and rat mammary cell differentiation. Endocrinology 1990;128:1574-1579.
31. Koshimoto HN, Tokuda M, Matsui H, Itano T, Hasegawa E, Hatase O. Involvement of lipocortin I in development galactose-induced cataracts in rat. Exp Eye Res 1992;54:817-819.
32. Schlaepfer DD, Haigler HT. Expression of annexins as a function of cellular growth state. J Cell Biol 1990;111:229-238.
33. Masaki T, Tokuda M, Fujiwara T, Ohnishi M, Tai Y, Miyamoto K, Itano T, et al. Involvement of annexin I and annexin II in hepatocyte proliferation: can annexins I and II be markers for proliferative hepatocytes? HEPATOLOGY 1994;20:425-435.
34. Tait JF, Sakata M, McMullen BA, Miano CH, Funakoshi T, Hendrickson L, Fujikawa K. Placental anticoagulant proteins: isolation and characterization of four members of the lipocortin family. Biochemistry 1988;27: 6268-6276.
35. Hirata F, Iwata M. Role of lipomodulin, a phospholipase inhibitory protein, in immunoregulation by thymocytes. J Immunol 1983;130:1930-1936.
36. Roy-Choudhury S, Mishra VS, Low MG, Das M. A phospholipid is the membrane anchoring domain of a protein growth factor of molecular mass 34 kDa in placental trophoblasts. Proc Natl Acad Sci U S A 1988;85:2014-2018.
37. Ulrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 1990;61:203-212.
38. Cooper JA, Hunter T. Identification and characterization of cellular targets for tyrosine protein kinases. J Biol Chem 1983;258:1108-1115.
39. Moll R, Franke WW, Schiller DL. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982;31:11-24.
40. Pack R, Heck R, Dienes HP, Oesch F, Steinberg P. Isolation, biochemical characterization, long-term culture, and phenotype modulation of oval cells from carcinogen-fed rats. Exp Cell Res 1993;204:198-209.
41. Pepinsky RB, Sinclair LK, Liang C-M, Browning JL. Monoclonal antibodies to lipocortin-I as probes for biological function. FEBS Lett 1990;198: 361-364.
42. Fairman MP. DNA polymerase d/PCNA: actions and interactions. J Cell Sci 1990;95:1-4.
43. Garland P, Degraef C. Cyclin/PCNA immunostaining as an alternative to tritiated thymidine pulse labeling for marking S phase cells in paraffin sections from animal and human tissues. Cell Tissue Kinet 1989;22:383-392.
44. Hall PA, Levision DA, Woods AL, Yu CC-W, Kellock DB, Watkins JA, Barnes DM, et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1990;138:1471-1477.
45. Kamel OW, LeBrun DP, Davis RE, Berry GJ, Warnke RA. Growth fraction estimation of malignant lymphomas in formalin-fixed paraffin-embedded tissue using anti-PCNA/cyclin 19A2. Am J Pathol 1991;138:1471-1477.
46. Wolf HK, Michalopoulos GK. Hepatocyte regeneration in acute fulminant hepatitis: A study of proliferating cell nuclear antigen expression. HEPATOLOGY 1992;15:707-713.
47. Kanakura Y, Druker B, DiCarlo J, Cannistra SA, Griffin JD. Phorbol 12-myristate 13-acetate inhibits granulocyte-macrophage colony stimulating factor-induced protein tyrosine phosphorylation in a human factor-dependent hematopoietic cell line. J Biol Chem 1991;266:490-495.
48. Druker BJ, Mamon HJ, Roberts TM. Oncogenes, growth factors, and signal transduction. N Engl J Med 1989;321:1383-1391.
49. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.
50. Towbin H, Stadhelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 1979;76:4350-4354.
51. Liver Cancer Study Group of Japan. The general rules for the clinical and pathological study of primary liver cancer. 3rd ed. Kyoto: Kimbara, 1992: 34-35.
52. Edmondson HA, Steiner PE. Primary carcinoma of the liver. A study of 100 cases among 48,900 necropsies. Cancer 1954;7:462-503.
53. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
54. Noji S, Takahashi N, Nohno T, Koyama E, Yamaai T, Muramatsu M, Taniguchi S. Expression pattern of the homeobox gene Hox-3.5 during development as revealed by a simplified in situ hybridization method. Acta Histochem Cytochem 1990;23:353-366.
55. Hunter T, Sefton BM. Transforming gene product of Rous sarcoma virus phosphorylates tyrosine. Proc Natl Acad Sci U S A 1980;77:1311-1315.
56. Marker AJ, Galloway E, Palmer S, Nakamura T, Gould GW, MacSween RN, Bushfield M. Role of the adenylate cyclase, phosphoinositidase C and receptor tyrosyl kinase systems in the control of hepatocyte proliferation by hepatocyte growth factor. Biochem Pharmacol 1992;44:1037-1043.
57. Blackwell GJ, Carnuccio R, Dirosa M, Flower RJ, Langham CSJ, Parente L, Persico P, et al. Glucocorticoids induce the formation and release of anti-inflammatory and anti-phospholipase proteins into the peritoneal cavity of the rat. Br J Pharmacol 1982;76:185-194.
58. Cirino G, Flower RJ, Browning JL, Sinclair LK, Pepinsky RB. Recombinant human lipocortin I inhibits thromboxane release from guinea-pig isolated perfused lung. Nature 1987;328:270-272.
59. Hirata F. The regulation of lipomodulin, a phospholipase inhibitory protein, in rabbit neutrophils by phosphorylation. J Biol Chem 1981;256: 7730-7733.
60. Sato EF, Miyahara M, Utsumi K. Purification and characterization of a lipocortin from guinea pig neutrophils. FEBS Lett 1988;227:131-135.
61. Pradel LA, Rendon A. Annexin I is present in different molecular forms in rat cerebral cortex. FEBS Lett 1993;327:41-44.
62. 2 protein indistinguishable from lipocortin. Nature 1986;321:177-180.
63. Hsia CC, Li TS, Li YS, Sun Z, Wang NJ, Shao LC, Zhang SP. Liver cell cancer in the young and adolescent and its relation to hepatitis B virus. Chin J Oncol 1984;6:413-416.